Fixed-dose combination drug therapies give rise to innovation in solid-dosage formulations and manufacturing. As pharmaceutical companies face shortfalls in R&D productivity and increased generic-drug ...
Canagliflozin Provided Substantial and Sustained Glycemic Improvements as Monotherapy and in Add-On Combinations in Adults with Type 2 Diabetes in Five Phase 3 Studies Canagliflozin Provides Greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback